EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in Lysine Methylation Contribute to the Cytotoxicity of Curcumin in Colon Cancer Cells

Roberta Santarelli iD, Paola Currà, Michele Di Crosta, Roberta Gonnella iD, Maria Saveria Gilardini Montani iD, Mara Cirone iD

Molecules · 2025

DOI: 10.3390/molecules30020335 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Roberta Santarelli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy. Hauptthemen laut MEDLINE: Curcumin, Colonic Neoplasms, Lysine, Antineoplastic Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epigenetic abnormalities play a critical role in colon carcinogenesis, making them a promising target for therapeutic interventions. In this study, we demonstrated that curcumin reduces colon cancer cell survival and that a decrease in lysine methylation was involved in such an effect. This correlated with the downregulation of methyltransferases EZH2, MLL1, and G9a, in both wild-type p53 (wtp53) HCT116 cells and mutant p53 (mutp53) SW480 cells, as well as SET7/9 specifically in wtp53 HCT116 cells. The effects induced by curcumin were more pronounced in wtp53 cells, where it induced a stronger apoptosis and ferroptosis. Interestingly, curcumin also reduced mutp53 expression, suggesting that it could enhance the efficacy of other therapies, particularly in overcoming drug resistance mechanisms associated with mutp53. For instance, in this study, we show that curcumin sensitized SW480 cells to SET7/9 inhibition by sinefungin, further supporting its potential as a combinatorial therapeutic agent. However, although to a lesser extent, curcumin also impaired cell survival in HCT 116 p53 null cells, suggesting that other molecular pathways or factors, beyond p53, may be involved in curcumin-induced cytotoxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CurcuminColonic NeoplasmsLysineAntineoplastic AgentsHumansMethylationHCT116 CellsCell SurvivalApoptosisCell Line, TumorTumor Suppressor Protein p53Histone-Lysine N-MethyltransferaseGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

acetylationcolon cancercurcuminepigeneticmethylationmethyltransferasemutp53wtp53

Substanzen

CurcuminLysineTumor Suppressor Protein p53Histone-Lysine N-MethyltransferaseAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.

ORCID-Profile: Roberta Santarelli, Roberta Gonnella, Maria Saveria Gilardini Montani, Mara Cirone

Förderung

  • Italian Association for Cancer Research

Zitieren

APA

Santarelli, R., Currà, P., Di Crosta, M., Gonnella, R., Gilardini Montani, M. S., & Cirone, M. (2025). Changes in Lysine Methylation Contribute to the Cytotoxicity of Curcumin in Colon Cancer Cells. Molecules. https://doi.org/10.3390/molecules30020335

Vancouver

Santarelli R, Currà P, Di Crosta M, Gonnella R, Gilardini Montani MS, Cirone M. Changes in Lysine Methylation Contribute to the Cytotoxicity of Curcumin in Colon Cancer Cells. Molecules. 2025. doi:10.3390/molecules30020335

BibTeX
@article{Santarelli2025,
  author = {Santarelli, Roberta and Currà, Paola and Di Crosta, Michele and Gonnella, Roberta and Gilardini Montani, Maria Saveria and Cirone, Mara},
  title = {Changes in Lysine Methylation Contribute to the Cytotoxicity of Curcumin in Colon Cancer Cells},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30020335}
}
Kostenlos starten →